(July 17, 2019, 11:17 AM EDT) -- PHILADELPHIA — The Pennsylvania Superior Court on July 16 reversed a trial court’s compulsory nonsuit in a Risperdal gynecomastia case and remanded the case for a new trial, saying that under applicable Texas law, the plaintiffs presented sufficient prima facie evidence to support their claim (T.M., et al. v. Janssen Pharmaceuticals Inc., et al., No. 184-EDA 2018, Pa. Super., 2019 Pa. Super. LEXIS 708)....